Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide

This publication has 19 references indexed in Scilit:

• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
  Pharmacological Reviews, 2002
• The amyloid-β peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity
  Neuroscience Letters, 2002
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
  Nature, 2002
• Identification of amyloid-β binding sites using an antisense peptide approach
  NeuroReport, 2001
• 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB ₁ receptor
  Proceedings of the National Academy of Sciences, 2001
• Amyloid β neurotoxicity not mediated by the mitogen-activated protein kinase cascade in cultured rat hippocampal and cortical neurons
  Neuroscience Letters, 2000
• Amyloid-β binds catalase with high affinity and inhibits hydrogen peroxide breakdown
  Biochemical Journal, 1999
• β-amyloid peptide fragment 31–35 induces apoptosis in cultured cortical neurons
  Neuroscience, 1999
• Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in Culture
  The Journal of cell biology, 1998
• Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
  Science, 1992